Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol
Clinical trial NCT07564726 · COMPLETED
Trial details
- NCT number
- NCT07564726
- Sponsor
- Celltrion Pharm, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-05
- Primary completion
- 2024-02-13
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.